Over the past several years, interest in digital health tools and their applications in mental health has increased significantly. Digital technologies enable the collection of high quality phenotypic and behavioural data which has the potential to change the way we diagnose, monitor and develop therapies for psychiatric disease. Among these tools, speech-based biomarkers, including those being developed at Winterlight Labs, show strong potential for remote monitoring, characterizing mental states and objectively tracking changes over time. In this Webinar we will discuss:
- How speech biomarkers can be used in clinical research and drug development?
- How does speech change in different psychiatric conditions?
- The potential prognostic value of measuring speech to track remission and relapse?
- How high frequency monitoring of speech can provide sensitive symptom monitoring?